Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer

Australian and US MedTech startup Nutromics (Nutromics or the Company), a global leader in DNA-based biosensors, announc...

April 12, 2022 | Tuesday | News
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly

Australia's Telix Pharmaceuticals has entered into a licence agreement with Eli Lilly and Company under which Telix is g...

April 11, 2022 | Monday | News
Medriva announces availability of new COVID-19 Rapid Antigen Test kits in Australia

Medriva, a leading global manufacturer of COVID-19 testing and vaccination products, has announced the Australian a...

April 8, 2022 | Friday | News
Australia finds antimicrobial resistance making UTIs more deadly

A new study led by Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisati...

April 7, 2022 | Thursday | News
PSMA-PET Imaging to be funded through medicare in Australia from July 2022

Telix Pharmaceuticals Limited welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomogr...

April 7, 2022 | Thursday | News
Microba, Ginkgo Bioworks partner to discover novel live biotherapeutics

Microba Life Sciences, a precision microbiome science company, and Ginkgo Bioworks , the leading horizontal platfor...

April 6, 2022 | Wednesday | News
Australia launches flagship biological storage facility 'Biobanking Victoria'

Monash University has officially launched Australia’s first industry-focused storage facility for biological mater...

April 6, 2022 | Wednesday | News
Trescal launches single source calibration solution across Australia and New Zealand

Trescal, the global leader in calibration services, has announced the launch of its single source instrumentation soluti...

April 5, 2022 | Tuesday | News
Australia's Microba completes successful IPO

Australia-based Microba Life Sciences commences trading on the Australian Securities Exchange following the completion o...

April 5, 2022 | Tuesday | News
Telix's Illuccix launches in the US

Australia's Telix Pharmaceuticals announced that its prostate cancer imaging agent, Illuccix (kit for preparation o...

April 4, 2022 | Monday | News
Telix, GMS and Monash awarded $23M from government

Telix Pharmaceuticals has announced that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) P...

April 4, 2022 | Monday | News
New trial in Australia could help increase supply of Japanese encephalitis vaccine

A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...

April 1, 2022 | Friday | News
Beroni Group announces appointment of Dr. John Chiplin to Board of Directors

Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...

April 1, 2022 | Friday | News
Australia make medicines more affordable

Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from toda...

April 1, 2022 | Friday | News
Sonoma Pharmaceuticals launches new UTI product in Australia and NewZealand

US-based Sonoma Pharmaceuticals, a global healthcare leader developing and producing patented Microcyn technology based ...

March 31, 2022 | Thursday | News
Baymatob completes capital raise to advance life-saving labor monitoring device

Australian Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used to continue ...

March 30, 2022 | Wednesday | News
Australia invests $537 B in healthcare over next four years

The Coalition Government in Australia is investing in a stronger health system as part of its plan for a stronger future...

March 30, 2022 | Wednesday | News
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix

Australia-based Telix Pharmaceuticals has signed an exclusive agreement with Xiel Limited (Xiel) for the distributi...

March 29, 2022 | Tuesday | News